|
1
|
Simonson DC: Etiology and prevalence of
hypertension in diabetic patients. Diabetes Care. 11:821–827. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garcia MJ, McNamara PM, Gordon T and
Kannel WB: Morbidity and mortality in diabetics in the Framingham
population. Sixteen year follow-up study. Diabetes. 23:105–111.
1974. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haffner SM, Lehto S, Rönnemaa T, Pyörälä K
and Laakso M: Mortality from coronary heart disease in subjects
with type 2 diabetes and in nondiabetic subjects with and without
prior myocardial infarction. N Engl J Med. 339:229–234. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang Z and Klionsky DJ: Eaten alive: A
history of macroautophagy. Nat Cell Biol. 12:814–822. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: Crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nishida K, Kyoi S, Yamaguchi O, Sadoshima
J and Otsu K: The role of autophagy in the heart. Cell Death
Differ. 16:31–38. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gustafsson AB and Gottlieb RA: Autophagy
in ischemic heart disease. Circ Res. 104:150–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Munasinghe PE, Riu F, Dixit P, Edamatsu M,
Saxena P, Hamer NS, Galvin IF, Bunton RW, Lequeux S, Jones G, et
al: Type-2 diabetes increases autophagy in the human heart through
promotion of Beclin-1 mediated pathway. Int J Cardiol. 202:13–20.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li ZL, Woollard JR, Ebrahimi B, Crane JA,
Jordan KL, Lerman A, Wang SM and Lerman LO: Transition from obesity
to metabolic syndrome is associated with altered myocardial
autophagy and apoptosis. Arterioscler Thromb Vasc Biol.
32:1132–1141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mellor KM, Bell JR, Young MJ, Ritchie RH
and Delbridge LM: Myocardial autophagy activation and suppressed
survival signaling is associated with insulin resistance in
fructose-fed mice. J Mol Cell Cardiol. 50:1035–1043. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sciarretta S, Volpe M and Sadoshima J:
Mammalian target of rapamycin signaling in cardiac physiology and
disease. Circ Res. 114:549–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kubli DA and Gustafsson AB: Cardiomyocyte
health: Adapting to metabolic changes through autophagy. Trends
Endocrinol Metab. 25:156–164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Christensen DP, Dahllöf M, Lundh M,
Rasmussen DN, Nielsen MD, Billestrup N, Grunnet LG and
Mandrup-Poulsen T: Histone deacetylase (HDAC) inhibition as a novel
treatment for diabetes mellitus. Mol Med. 17:378–390. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sharma S and Taliyan R: Histone
deacetylase inhibitors: Future therapeutics for insulin resistance
and type 2 diabetes. Pharmacol Res. 113:320–326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kao YH, Liou JP, Chung CC, Lien GS, Kuo
CC, Chen SA and Chen YJ: Histone deacetylase inhibition improved
cardiac functions with direct antifibrotic activity in heart
failure. Int J Cardiol. 168:4178–4183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee TI, Kao YH, Tsai WC, Chung CC, Chen YC
and Chen YJ: HDAC inhibition modulates cardiac PPARs and fatty acid
metabolism in diabetic cardiomyopathy. PPAR Res. 2016:59387402016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brownlee M: Biochemistry and molecular
cell biology of diabetic complications. Nature. 414:813–820. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barlovic DP, Soro-Paavonen A and
Jandeleit-Dahm KA: RAGE biology, atherosclerosis and diabetes. Clin
Sci (Lond). 121:43–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mansor LS, Gonzalez ER, Cole MA, Tyler DJ,
Beeson JH, Clarke K, Carr CA and Heather LC: Cardiac metabolism in
a new rat model of type 2 diabetes using high-fat diet with low
dose streptozotocin. Cardiovasc Diabetol. 12:1362013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee TI, Kao YH, Chen YC, Pan NH, Lin YK
and Chen YJ: Cardiac peroxisome-proliferator-activated receptor
expression in hypertension co-existing with diabetes. Clin Sci
(Lond). 121:305–312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee TI, Chen YC, Kao YH, Hsiao FC, Lin YK
and Chen YJ: Rosiglitazone induces arrhythmogenesis in diabetic
hypertensive rats with calcium handling alteration. Int J Cardiol.
165:299–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lkhagva B, Lin YK, Kao YH, Chazo TF, Chung
CC, Chen SA and Chen YJ: Novel histone deacetylase inhibitor
modulates cardiac peroxisome proliferator-activated receptors and
inflammatory cytokines in heart failure. Pharmacology. 96:184–191.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cefalu WT: Animal models of type 2
diabetes: Clinical presentation and pathophysiological relevance to
the human condition. ILAR J. 47:186–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boden G, Lebed B, Schatz M, Homko C and
Lemieux S: Effects of acute changes of plasma free fatty acids on
intramyocellular fat content and insulin resistance in healthy
subjects. Diabetes. 50:1612–1617. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haffner SM: American Diabetes Association:
Management of dyslipidemia in adults with diabetes. Diabetes care.
26 Suppl 1:S83–S86. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reaven GM, Hollenbeck C, Jeng CY, Wu MS
and Chen YD: Measurement of plasma glucose, free fatty acid,
lactate, and insulin for 24 h in patients with NIDDM. Diabetes.
37:1020–1024. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shulman GI: Cellular mechanisms of insulin
resistance. J Clin Invest. 106:171–176. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Srinivasan K, Viswanad B, Asrat L, Kaul CL
and Ramarao P: Combination of high-fat diet-fed and low-dose
streptozotocin-treated rat: A model for type 2 diabetes and
pharmacological screening. Pharmacol Res. 52:313–320. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singh R and Cuervo AM: Autophagy in the
cellular energetic balance. Cell Metab. 13:495–504. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sciarretta S, Zhai P, Shao D, Maejima Y,
Robbins J, Volpe M, Condorelli G and Sadoshima J: Rheb is a
critical regulator of autophagy during myocardial ischemia:
Pathophysiological implications in obesity and metabolic syndrome.
Circulation. 125:1134–1146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He C, Zhu H, Li H, Zou MH and Xie Z:
Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances
cardiac autophagy and protects against cardiomyocyte apoptosis in
diabetes. Diabetes. 62:1270–1281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo R, Zhang Y, Turdi S and Ren J:
Adiponectin knockout accentuates high fat diet-induced obesity and
cardiac dysfunction: Role of autophagy. Biochim Biophys Acta.
1832:1136–1148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu X and Ren J: Macrophage migration
inhibitory factor (MIF) knockout preserves cardiac homeostasis
through alleviating Akt-mediated myocardial autophagy suppression
in high-fat diet-induced obesity. Int J Obes (Lond). 39:387–396.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Inoki K, Zhu T and Guan KL: TSC2 mediates
cellular energy response to control cell growth and survival. Cell.
115:577–590. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lum JJ, DeBerardinis RJ and Thompson CB:
Autophagy in metazoans: Cell survival in the land of plenty. Nat
Rev Mol Cell Biol. 6:439–448. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun L, Ishida T, Yasuda T, Kojima Y, Honjo
T, Yamamoto Y, Yamamoto H, Ishibashi S, Hirata K and Hayashi Y:
RAGE mediates oxidized LDL-induced pro-inflammatory effects and
atherosclerosis in non-diabetic LDL receptor-deficient mice.
Cardiovasc Res. 82:371–381. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zisman A, Peroni OD, Abel ED, Michael MD,
Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF,
Virkamaki A, Goodyear LJ, et al: Targeted disruption of the glucose
transporter 4 selectively in muscle causes insulin resistance and
glucose intolerance. Nat Med. 6:924–928. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin HV, Ren H, Samuel VT, Lee HY, Lu TY,
Shulman GI and Accili D: Diabetes in mice with selective impairment
of insulin action in Glut4-expressing tissues. Diabetes.
60:700–709. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chao KC, Chao KF, Fu YS and Liu SH:
Islet-like clusters derived from mesenchymal stem cells in
Wharton's Jelly of the human umbilical cord for transplantation to
control type 1 diabetes. PLoS One. 3:e14512008. View Article : Google Scholar : PubMed/NCBI
|
